Results 41 to 50 of about 18,009 (224)
Arthritis &Rheumatology, EarlyView.Objective Regeneration and expansion of Treg by low‐dose interleukin‐2 (IL‐2) therapy is considered a potential treatment strategy for a wide range of autoimmune diseases. To provide a pathophysiologically‐based rationale for low‐dose IL‐2 therapy, we investigated whether reversible defects in the Treg–IL‐2 axis emerge in inflammatory myopathies ...
Justus Ohmes +10 more
wiley +1 more source
Diagnosis dan Tatalaksana Polymyositis [PDF]
, 2015 Polymyositis adalah miopati inflamasi idiopatik yang menyebabkan kelemahan otot simetris proksimal, peningkatan kadar enzim otot rangka, serta elektromiografi (EMG) dan temuan biopsi otot yang spesifik.
Yonata, Ade
core
Polymyositis and vaginal carcinoma
, 1993 The strange association of Dermatomyositis-Polymyositis (DM-PM) and cancer has been known for many years. We present the case of a 57-year-old woman with polymyositis refractory to steroid therapy, in whom extensive investigation finally revealed a ...
Selvaggi L. +3 more
core +1 more source
COULD ANTI-SYNTHETASE SYNDROME BE A GOOD PREDICTOR FACTOR FOR INTERSTITIAL LUNG DISEASE? [PDF]
Romanian Journal of Rheumatology, 2017 Anti-synthetase syndrome (SAS) is an autoimmune inflammatory myopathy, whose immune profile is dominated by anti-RNA synthetase antibodies (ARS), with a specific clinical phenotype.
Sineta Cristina Firulescu +8 more
doaj +1 more source
Atypical Presentation of Antisynthetase Syndrome: A Case Report
Medical Journal of Dr. D.Y. Patil Vidyapeeth, 2023 Antisynthetase syndrome is characterized by autoantibodies against one of many aminoacyl transfer RNA synthetases. The clinical features include interstitial lung disease (ILD), non-erosive arthritis, Raynaud’s phenomenon, myositis, unexplained fever ...
Shalesh Rohatgi +3 more
doaj +1 more source
Arthritis &Rheumatology, Accepted Article.Objective We evaluated baseline characteristics, treatment patterns, and outcomes in patients with systemic autoimmune rheumatic disease‐associated progressive pulmonary fibrosis (SARD‐PPF) and evaluated whether outcomes differed by SARD subtype. Methods The ILD‐PRO Registry is a prospective multicenter US registry of patients with PPF.
Sonali J Bracken +7 more
wiley +1 more source
Updated COVID‐19 Vaccines and Health Outcomes in Patients With Autoimmune Rheumatic Conditions
Arthritis &Rheumatology, EarlyView.Objective We aimed to assess the association between COVID‐19 vaccination status and COVID‐19‐related hospital admissions, need for mechanical ventilation or extracorporeal membrane oxygenation (ECMO), and death in people with autoimmune rheumatic conditions. Methods We conducted a retrospective cohort study using National Clinical Cohort Collaborative
Lesley E. Jackson +127 more
wiley +1 more source
Case Reports in Rheumatology, 2019 Polymyositis-dermatomyositis is extremely rare during pregnancy, and immunosuppressive therapy should be administered after carefully considering the effects on both the mother and fetus.
Saito Mayu +8 more
doaj +1 more source
Polymyositis as a manifestation of chronic graft‐versus‐host disease after allo‐HSCT
Clinical Case Reports, 2018 Key Clinical Message Patients who received allogeneic haematopoietic stem cell transplantation (allo‐HSCT) may develop T cell‐mediated immunologic injury to muscles, recapitulating the characteristics of polymyositis clinically and pahtologically ...
Lijuan Meng +3 more
doaj +1 more source